PubMed Health⌕ Search

Biomedical subjects

J Halme

Publications and source records attributed to J Halme.

At least 19 recordsLinked to original sources

A case of severe ovarian hyperstimulation in a healthy oocyte donor.

OBJECTIVE: To report an unexpected case of severe ovarian hyperstimulation syndrome (OHSS) and to compare E2 levels and number of follicles to other oocyte donors. SETTING: Private assisted reproduction technology center. PATIENTS: Healthy oocyte donors with normal menstrual cyclicity. INTERVENTIONS: Prophylactic and therapeutic use of human serum albumin infusions. MAIN OUTCOME MEASURE: The clinical development of signs and symptoms of severe OHSS. RESULTS: More than 60% of other oocyte donors had higher E2 levels and 12% had higher number of follicles without associated OHSS. CONCLUSION: The risk of developing severe OHSS cannot be predicted accurately to be low even in the absence of "risk factors."

Adult↗

The effect of growth factors on the proliferation of human endometrial stromal cells in culture.

OBJECTIVE: Development of ectopic implants of endometriosis is associated with both an inflammatory response by macrophages and endometrial stromal cell proliferation. Macrophages are capable of releasing a variety of inflammatory mediators, including growth factors. To assess the impact of such factors on endometrial tissue, we have studied the effects of recombinant growth factors, fibroblast growth factor, epidermal growth factor, transforming growth factor-alpha, and inflammation mediators transforming growth factor-beta, and tumor necrosis factor-alpha on human endometrial stromal cell proliferation. STUDY DESIGN: Increasing concentrations of these compounds were added to cultures of primary, secondary, and long-term stromal cells and the cells were harvested at 24, 48, and 72 hours. RESULTS: Epidermal growth factor, transforming growth factor-alpha, transforming growth factor-beta, and fibroblast growth factor induced a statistically significant, dose-dependent increase in stromal cell thymidine uptake of 1.5- to fivefold. The cytokine tumor necrosis factor had no effect alone, but the combination of fibroblast growth factor and tumor necrosis factor had a synergistic effect, increasing cell proliferation 25% to 84% over fibroblast growth factor alone. CONCLUSION: The stromal cell response to a wide range of cell growth effectors and the potential of mediators like tumor necrosis factor-alpha to synergize suggest that such macrophage-secretory products may contribute to proliferation of endometrial implants in vivo.

Cell Division↗

Selective localization of interleukin-1 receptor antagonist in eutopic endometrium and endometriotic implants.

OBJECTIVES: To determine whether interleukin-1 receptor antagonist (IL-1ra) expression was concordant in eutopic endometrium and endometriotic implants. DESIGN: Paired samples of endometrium and endometriotic implants from eight patients with endometriosis were used. MAIN OUTCOME MEASURES: Interleukin-1 receptor antagonist was demonstrated immunohistochemically on frozen sections of eutopic and ectopic endometria. A sandwich technique with polyclonal rabbit anti-IL-1ra antibody and an avidin-biotin reagent (Vector Laboratories, Inc. Burlingame, CA) was used. RESULTS: Seven of eight (88%) eutopic endometrial sections revealed staining of glandular epithelium with complete absence of any staining of the stromal compartment. In the counterpart sections of endometriosis, the glandular as well as the stromal compartments were negative for IL-1ra in all patients. CONCLUSION: These data suggest a differential production of the IL-1ra in eutopic endometrium and endometriotic implants. The potential clinical implications of this finding are discussed.

Adult↗

Endometriosis: the host response.

There is abundant evidence of altered immune function in endometriosis. The task that remains is to attempt a synthesis from the accumulated data, to try to make some sense of the observed phenomena and to fit them into a conceptual framework; this might permit the formulation and testing of hypotheses. Evidently, eutopic endometrium does not engender an immune response in normal subjects, otherwise the endometrium would be subject to autoimmune destruction. It has also been established that the overwhelming majority of women regurgitate menstrual debris into the peritoneal cavity. Why does this lead to endometriosis in some, but not in others? There are several possible explanations. The uterus might act as a privileged site, i.e. be exempt from immune effector mechanisms. This would certainly be conducive to the reproductive goal, the survival of the fetal allograft. Endometrium would then not enjoy the immunologic tolerance of most other tissues, and upon leaving the uterus and entering an immunocompetent environment would be subject to immune attack. In normal subjects, this could consist of elimination of menstrual debris without further sequelae. An altered response, characterized by the production of antibody that could mask receptors for cytotoxic or phagocytic effector cells, would permit persistence of ectopic endometrium. The alternative to this hypothesis is that the uterus is not a privileged site, and that the organism is normally tolerant to endometrial antigens. Menstrual debris would be eliminated intraperitoneally without loss of tolerance due to the presence of homeostatic mechanisms including suppressor T cells and suppressive cytokines. In endometriosis, this tolerance breaks down, as is the case in several autoimmune disorders, causing a chronic inflammatory response with the release of toxic factors and, eventually, peritoneal scarring. Finally, the role of cell adhesion molecules, including the integrins, is only just being explored. The behaviour of these molecules in ectopic endometrium differs from that in eutopic endometrium, and it remains to be seen whether regurgitated endometrial debris from normal subjects is different from that of endometriosis sufferers. It seems that this will be an area of intense investigation in the immediate future.

Autoimmune Diseases↗

Effects of carbon dioxide-saturated normal saline and Ringer's lactate on postsurgical adhesion formation in the rabbit.

OBJECTIVE: To evaluate the effect of combining carbon dioxide gas (CO2) with normal saline versus CO2 with lactated Ringer's solution on adhesion formation in the rabbit model. METHODS: Sixty New Zealand white rabbits underwent surgery based on a proven experimental adhesion model. Following abdominal closure, the animals were randomly assigned to three groups: Group 1 underwent abdominal CO2 insufflation only; group 2 underwent abdominal irrigation with CO2-saturated normal saline; group 3 underwent abdominal irrigation with CO2-saturated lactated Ringer's solution. Three weeks later, the rabbits were sacrificed and the adhesions were scored in a blinded fashion based on the extent, type, and tenacity, with a maximum possible score of 11. RESULTS: The mean (+/- standard deviation) adhesion scores were 7.75 +/- 2.82 in group 1, 7.85 +/- 2.58 in group 2, and 4.75 +/- 2.95 in group 3. There was no difference in severity of adhesions between groups 1 and 2. However, the mean adhesion score was significantly lower in group 3 (lactated Ringer's with CO2) than in either group 1 (CO2) or group 2 (normal saline with CO2) (P = .004 and P = .002, respectively). CONCLUSION: It appears that when CO2 is the insufflating gas, lactated Ringer's solution has a protective effect against adhesion formation in the rabbit model.

Animals↗

Immunohistochemical detection of type I, III, and IV collagen in endometriosis implants.

OBJECTIVE: To determine if types I, III, or IV collagen are present in ectopic endometrium and to determine which type(s) of collagen are present in the connective tissue surrounding ectopic endometrial implants. DESIGN: Paired intrauterine and ectopic endometrial samples were obtained for study at the time of laparoscopy from women in the proliferative and secretory phase of the menstrual cycle. Connective tissue surrounding each ectopic implant was also obtained for study. SETTING: Academic research environment with institutional review board approval. PATIENTS: Six patients without endometriosis were used as controls. Ten additional patients with stage II or III endometriosis were studied. Only women on no medications participated in the study. MAIN OUTCOME MEASURES: Immunohistochemical techniques were used to identify the presence of collagen in biopsied specimens. RESULTS: Each collagen type studied was identified in the intrauterine endometrium of patients with and without endometriosis. All collagen types were also identified in each of the ectopic endometrial implants studied. The distribution of collagen in ectopic endometrial implants was similar to the distribution of collagen seen in intrauterine endometrium obtained from patients with or without endometriosis. Collagenous tissue that contained type I collagen was identified at the periphery of deep ectopic implants. CONCLUSIONS: This study demonstrates the presence of type I, III, and IV collagen in the intrauterine and ectopic endometrium of patients with endometriosis. Type I collagen was the predominant collagen present in the surrounding collagenous tissue associated with deep, ectopic endometrial implants.

Collagen↗

Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro.

OBJECTIVE: To assess the direct effects of three endometriosis chemotherapeutic agents (medroxyprogesterone acetate [MPA], danazol, and leuprolide acetate [LA]) on endometrial cell proliferation. DESIGN: Analysis of cell proliferation in vitro. SETTING: Proliferative phase endometrial stromal cells isolated from biopsy specimens and grown in short-term culture served as a model for stromal components of endometriotic implants. PATIENTS: Biopsies obtained from volunteers with regular cycles and without endometriosis or endometrial pathology. INTERVENTIONS: Medroxyprogesterone acetate, danazol, and LA were added to nutrient media with the following supplements: 2.5% calf serum (CS) only; 2.5% CS+estradiol (E2) 110 pmol/L; 2.5% CS+E2 550 pmol/L; 10% preovulatory serum (net E2 624 pmol/L). MAIN OUTCOME MEASURES: Cumulative [3H]-thymidine incorporation as a reflection of cell proliferation. RESULTS: Medroxyprogesterone acetate and danazol exerted significant antiproliferative effects on stromal cell proliferation (P less than 0.05), effects that were enhanced by an absence of exogenous E2. Leuprolide acetate exerted no consistent effects. CONCLUSIONS: These data imply that MPA and danazol but not LA exert direct effects, suppressing growth of endometriotic implants.

Adult↗

Interleukin-1 inhibits growth of normal human endometrial stromal cells.

OBJECTIVE: To understand growth regulation of the endometrium by studying the effect of interleukin-1 beta (IL-1) on human endometrial stromal cell proliferation in vitro. METHODS: Endometrial stromal cells from human endometrium were separated and purified and placed in culture. Fresh and first- and sixth-passage cells were incubated with IL-1 (0.025, 0.25, and 2.5 ng/mL) for 24, 48, and 72 hours, respectively. Proliferation as a function of DNA synthesis was assessed by measuring 3H-thymidine incorporation. Experiments were then repeated in the presence of indomethacin to determine whether IL-1 effects were dependent upon prostaglandin synthesis. We evaluated overall growth by adding IL-1 to cell cultures of sixth-passage stromal cells every 3 days and by performing cell count studies. RESULTS: Interleukin-1 beta significantly inhibited 3H-thymidine uptake in freshly explanted endometrial stromal cells at all doses in a dose-dependent manner; a 44% inhibition was seen at 2.5 ng/mL IL-1 after 72 hours of incubation. In first- and sixth-passage cells, 3H-thymidine uptake was inhibited only at intermediate and high doses of IL-1. Cell count studies showed that sixth-passage cells were significantly inhibited by IL-1 after 23 days of growth (22%; P less than .01). Adding indomethacin did not affect inhibition of growth. CONCLUSION: Interleukin-1 beta inhibits growth of normal human endometrial stromal cells in vitro and does not appear to be mediated by arachidonic acid metabolites. This inhibition of growth may be important for maintenance of a normal endometrial phenotype.

Cell Division↗

Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: a model for endometriosis?

OBJECTIVE: To assess the direct effects of platelet-derived growth factor (PDGF), a macrophage secretory product structurally and functionally similar to substances released by peritoneal macrophages isolated from endometriosis patients, on endometrial cell proliferation. DESIGN: Prospective analysis of cell proliferation in vitro. SETTING: Proliferative phase endometrial stromal cells isolated from biopsy specimens were grown in short-term culture and served as a model for stromal components of endometriotic implants. PATIENTS: Biopsies were obtained from regularly cycling volunteers without endometrial pathology. INTERVENTIONS: Platelet-derived growth factor was added to nutrient medium in both the presence and absence of suboptimal (2.5%) calf serum (CS) supplements and a physiological estradiol (E2) concentration (10(-9) M). MAIN OUTCOME MEASURES: Cumulative [3H]-thymidine incorporation as a reflection of cell proliferation. RESULTS: Platelet-derived growth factor exerted a significant dose-dependent effect on stromal cell proliferation in both the presence and absence of CS (P less than 0.01). This effect was enhanced in, at best, an additive but not synergistic manner by E2 10(-9) M. CONCLUSION: These data imply that macrophage secretory products such as PDGF may play a significant role in the maintenance or proliferation of endometriosis.

Adult↗

Role of peritoneal inflammation in endometriosis-associated infertility.

This paper has discussed the evidence for the presence of infertility in patients with endometriosis and more critically reviewed some of the studies that have addressed the impact of various potential local peritoneal mechanisms that may lead to subfertility. Substantial evidence supports the notion that patients with endometriosis have reduced fecundability. Although several mechanisms, including, e.g., anatomic factors and ovulatory dysfunction, are possible, recent studies have pointed towards local inflammatory cells and their secretory products as being important mediators of subfertility. Ample evidence exists for the presence of an altered peritoneal inflammatory environment in patients with endometriosis. In addition, in vitro studies have identified peritoneal macrophages and their secretory products, specifically TNF-alpha as the most likely contributors to the reduced fecundability through effects on sperm function.

Endometriosis↗

Endometriosis and associated pathology.

The natural history of endometriosis, including the belief that it is a progressive disease, is reviewed with the help of a large, cross-sectional, prospective study and a smaller longitudinal study. Two studies are reviewed that address the role of growth factors in the development of endometriosis. These studies demonstrated that the peritoneal fluid of patients with endometriosis contained significant growth factor activity against human endometrial stromal cells. In a mouse model, macrophage-derived factors stimulated endometrial cell proliferation. The possible correlation between endometriosis and decreased bone mineral density, which was reported by an earlier study, is reviewed. Recent data, however, have shown no correlation between bone mineral density and endometriosis. Finally, several reports on the usefulness of endometrial antibodies and serum CA 125 levels in the diagnosis and treatment of patients with endometriosis are reviewed. These data suggest that both endometrial antibodies and CA 125 measurements may be useful in the diagnosis and treatment of patients with endometriosis.

Adult↗

Release of tumor necrosis factor alpha by human peritoneal macrophages in response to toxic shock syndrome toxin-1.

We examined the release in vitro of tumor necrosis factor-alpha (TNF-alpha) by peritoneal macrophages and peripheral blood monocytes following incubation with toxic shock syndrome toxin-1 (TSST-1). We obtained peritoneal macrophages from 22 women at laparoscopy and peripheral blood monocytes from four healthy women during both the midfollicular and midluteal phases of the menstrual cycle. The samples were incubated for 24 hours at 37 C with 10(-2)-10(4) ng/mL of TSST-1 or 10(4) ng/mL of bacterial endotoxin. Tumor necrosis factor-alpha activity was determined with a bioassay using an actinomycin D-sensitized WEHI-164 murine fibrosarcoma cell line. Twenty-four-hour incubation with TSST-1 resulted in a dose-dependent release of TNF-alpha by both peritoneal macrophages (maximal response 554 +/- 97 U of activity) and peripheral blood monocytes (maximal response 478 +/- 81 U of activity). We observed enhanced TNF-alpha release by peritoneal macrophages from women with endometriosis, compared with those without endometriosis, at a concentration of 10(4) ng/mL of TSST-1 (704 +/- 134 versus 354 +/- 103 U of activity; P less than .05). These data support the theory that the metabolic and physiologic derangements of perimenstrual toxic shock syndrome may be partially mediated by TNF-alpha released by peritoneal macrophages as a result of exposure to TSST-1.

Adult↗

Effect of peritoneal fluid from endometriosis patients on endometrial stromal cell proliferation in vitro.

Late proliferative phase endometrial stromal cells grown in short-term culture were used as a model for the stromal component of endometriotic implants. Cells were grown in medium alone and in medium supplemented by 5, 10, and 20% concentrations of the cell-free fractions of peritoneal fluid obtained from patients with and without endometriosis. Nine fluid-sample pairs were matched based on the presence or absence of endometriosis at laparoscopy and the similarity of peritoneal fluid estradiol concentrations. Stromal cell proliferation as reflected by 3H-thymidine incorporation during sequential cell harvests over 72 hours was greater for cells exposed to endometriosis peritoneal fluid than for those exposed to non-endometriosis peritoneal fluid. This reached statistical significance with exposure to peritoneal fluid concentrations of 10 and 20% (P less than .05). A linear dose-response relationship between 3H-thymidine incorporation and peritoneal fluid concentration could be derived only for stromal cells exposed to fluid samples obtained from endometriosis patients (r = 0.51; P less than .001). In addition, proliferation over 72 hours was significantly greater for cells grown in 20% endometriosis peritoneal fluid than for those grown in nutrient medium alone (P less than .001). These data imply that factor(s) secreted into the peritoneal fluid of endometriosis patients may play a role in the proliferation or maintenance of disease implants.

Adult↗

Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro.

Tumor necrosis factor is a product of activated monocytes, macrophages, and lymphocytes that exerts a variety of effects in the host. Its cytotoxicity toward gametes has been suggested as a mechanism of how activated macrophages may cause subfertility, inasmuch as detectable levels of tumor necrosis factor have been reported in the peritoneal fluid of infertile patients. To further examine this issue we measured tumor necrosis factor activity in peritoneal fluid and its release in vitro from monocytes or peritoneal macrophages of patients undergoing laparoscopy because of either tubal ligation or infertility. Cytolytic activity was determined with a bioassay with sensitized mouse fibrosarcoma cells as target. Significant tumor necrosis factor activity (greater than 5 U/ml) was detected in 38% of the peritoneal fluid samples. A total of 43% of the peritoneal macrophage samples released significant tumor necrosis factor activity in vitro and all samples tested including peripheral monocytes released high levels of activity in the presence of bacterial endotoxin. The activity was released in vitro in a time-dependent manner. Thermal stability characteristics and neutralization with a specific antibody indicated that most of the activity in peritoneal fluid or released in vitro was that of tumor necrosis factor-alpha. Statistical analysis of tumor necrosis factor activity in peritoneal fluid in various diagnostic categories revealed a significantly elevated level in patients with endometriosis, as compared with fertile women. Endometriosis and pelvic adhesions were also significantly more likely to be associated with measurable levels of tumor necrosis factor activity released by peritoneal macrophages in vitro. Overall, because tumor necrosis factor-alpha levels were frequently detectable, it suggests that activation of peritoneal macrophages either by bacterial products or inflammatory conditions can occur in vivo. Moreover, these cells remain competent to release tumor necrosis factor in vitro.

Adult↗

Endometriosis as a cause of infertility.

Although association between moderate or severe endometriosis and infertility is fairly well established, the link between lesser disease stages and infertility is more tenuous. The proposed mechanisms underlying this association are reviewed. These include mechanical factors, changes in the peritoneal fluid environment, activation of local or systemic immune response, and abnormalities of ovulation, fertilization, and early pregnancy.

Abortion, Incomplete↗

Lower doses of human menopausal gonadotropin are associated with improved success with in vitro fertilization in women with low body weight.

Since previous data suggested hyperresponsiveness to human menopausal gonadotropin by women with low body weight, the daily dose was reduced to 1.5 ampules in patients undergoing in vitro fertilization weighing less than 55 kg. This allowed the extension of treatment to a minimum of 6 days. These changes were associated with improved results in in vitro fertilization in these women.

Body Weight↗

Normal human peritoneal macrophages are unable to cap and internalize class II antigens.

Normal human peritoneal macrophages show a restricted capacity to differentiate into inflammatory macrophages in vivo. We now report that these cells are unable to cap and internalize HLA-DR, as compared to endometriosis, and other macrophages. Immunoelectron microscopy indicated that lack of modulation was not due to the presence of preclustered antigenic sites. Northern blot analysis demonstrated transcripts for HLA.DR, c-fms, and c-fos, indicating that the surface defects were not likely to be associated with a general depression of transcriptional activity. There was no correlation between the mobility of class II molecules and the ability to present antigen as determined by autologous lymphocyte responses to tetanus toxoid. The inability of normal peritoneal macrophages to modulate class II antigens may represent a normal and more general environmental alteration required to permit peritoneal cells a scavenging function without developing the deleterious effects leading to a peritoneal inflammatory response.

Antibodies, Monoclonal↗